Corporate Travel Management CTM, one of Australia’s most prominent travel companies, faces mounting scrutiny after its suspension from the Australian Stock Exchange following the discovery of significant anomalies in its
All posts tagged in Australian Stock Exchange
2Articles
Syntara's $10M capital raise is propelling its drug development strategy into a new era. In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic deployment of funds.
